Aaltonen, J. (1998). Molecular Genetics of APECED (Academic dissertation).

Amiel, J., Attie, T., Jan, D., Pelet, A., Edery, P., Bidaud, C., Lacombe, D., Tam, P, Simeoni, J., Flori, E., Nihoul-Fekete, C., Munnich, A., and Lyonnet, S. (1996). Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Human Molecular Genetics 5, 355-357.

Angrist, M., Bolk, S., Halushka, M., Lapchak, P.A., and Chakravarti, A. (1996). Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nature Genetics 14, 341-344.

Angrist, M., Bolk, S., Thiel, B., Puffenberger, E.G., Hofstra, R.M., Buys, C.H., Cass, D.T., and Chakravarti, A. (1995). Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Human Molecular Genetics 4, 821-830.

Arce, V., Pollock, R.A., Philippe, J.M., Pennica, D., Henderson, C.E., deLapeyriere, O., (1998). Synergistic effects of schwann- and muscle-derived factors on motoneuron survival involve gdnf and cardiotrophin-1 (ct-1). Journal of Neuroscience 18, 1440-1448.

Arenas, E., Trupp, M., Akerud, P., and Ibanez, C.F. (1995). GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15, 1465-1473.

Arumäe, U., Sariola, H., and Haltia, M. (1997). (In Finnish) Apoptosis in developmental and degenerative diseases of the nervous system. Duodecim 113, 1590-1596.

Attie, T., Pelet, A., Edery, P., Eng, C., Mulligan, L.M., Amiel, J., Boutrand, L., Beldjord, C., Nihoul-Fekete, C., Munnich, A., et al. (1995). Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Human Molecular Genetics 4, 1381-1386.

Attie, T., Till, M., Pelet, A., Amiel, J., Edery, P., Boutrand, L., Munnich, A., and Lyonnet, S. (1995). Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Human Molecular Genetics 4, 2407-2409.

Auricchio, A., Casari, G., Staiano, A., and Ballabio, A. (1996). Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population. Human Molecular Genetics 5, 351-354.

Badner, J.A., Sieber, W.K., Garver, K.L., and Chakravarti, A. (1990). A genetic study of Hirschsprung disease. American Journal of Human Genetics 46, 568-580.

Baloh, R.H., Tansey, M.G., Golden, J.P., Creedon, D.J., Heuckeroth, R.O., Keck, C.L., Zimonjic, D.B., Popescu, N.C., Johnson, E.M., Jr., and Milbrandt, J. (1997). TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron 18, 793-802.

Barbacid, M. (1995). Neurotrophic factors and their receptors. Current Opinion in Cell Biology 7, 148-155.

Barde, Y.A., Edgar, D., and Thoenen, H. (1982). Purification of a new neurotrophic factor from mammalian brain. EMBO Journal 1, 549-553.

Baynash, A.G., Hosoda, K., Giaid, A., Richardson, J.A., Emoto, N., Hammer, R.E., and Yanagisawa, M. (1994). Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79, 1277-1285.

Beck, K.D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R.A., Rosenthal, A., and Hefti, F. (1995). Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.

Berkemeier, L.R., Ozcelik, T., Francke, U., and Rosenthal, A. (1992). Human chromosome 19 contains the neurotrophin-5 gene locus and three related genes that may encode novel acidic neurotrophins. Somatic Cell & Molecular Genetics 18, 233-245.

Berkemeier, L.R., Winslow, J.W., Kaplan, D.R., Nikolics, K., Goeddel, D.V., and Rosenthal, A. (1991). Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 7, 857-866.

Bermingham, N., Hillermann, R., Gilmour, F., Martin, J.E., and Fisher, E.M. (1995). Human glial cell line-derived neurotrophic factor (GDNF) maps to chromosome 5. Human Genetics 96, 671-673.

Bidaud, C., Salomon, R., Van Camp, G., Pelet, A., Attie, T., Eng, C., Bonduelle, M., Amiel, J., Nihoul-Fekete, C., Willems, P.J., Munnich, A., and Lyonnet, S. (1997). Endothelin-3 gene mutations in isolated and syndromic Hirschsprung disease. European Journal of Human Genetics 5, 247-251.

Bocciardi, R., Mograbi, B., Pasini, B., Borrello, M.G., Pierotti, MA, Bourget, I., Fischer, S., Romeo, G., and Rossi, B. (1997). The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. Oncogene 15, 2257-2265.

Boehnke, M., Lange, K., and Cox, D.R. (1991). Statistical methods for multipoint radiation hybrid mapping. American Journal of Human Genetics 49, 1174-1188.

Bongarzone, I., Pierotti, M.A., Monzini, N., Mondellini, P., Manenti, G., Donghi, R, Pilotti, S., Grieco, M., Santoro, M., Fusco, A., et al. (1989). High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 4, 1457-1462.

Bowenkamp, K.E., Lapchak, P.A., Hoffer, B.J., Miller, P.J., and Bickford, P.C. (1997). Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats. Experimental Neurology 145, 104-117.

Buck, C.R., Martinez, H.J., Black, I.B., and Chao, M.V. (1987). Developmentally regulated expression of the nerve growth factor receptor gene in the periphery and brain. Proceedings of the National Academy of Sciences of the United States of America 84, 3060-3063.

Buj-Bello, A., Adu, J., Piñón, L.G., Horton, A., Thompson, J., Rosenthal, A., Chinchetru, M., Buchman, V.L., and Davies, A.M. (1997). Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature 387, 721-724.

Bär, K.J., Facer, P., Williams, N.S., Tam, P.K.H., and Anand, P. (1997). Glial-derived neurotrophic factor in human adult and fetal intestine and in Hirschsprungs disease. Gastroenterology 112, 1381-1385.

Carlomagno, F., de Vita, G., Berlingieri, M.T., de Franciscis, V., Melillo, R.M., Colantuoni, V., Kraus, M.H., Di Fiore, P.P., Fusco, A., and Santoro, M. (1996). Molecular heterogeneity of RET loss of function in Hirschsprung's disease. EMBO Journal 15, 2717-2725.

Carter, B.D., Kaltschmidt, C., Kaltschmidt, B., Offenhauser, N., Bohm-Matthaei, R, Baeuerle, P.A., and Barde, Y.A. (1996). Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272, 542-545.

Casaccia-Bonnefil, P., Carter, B.D., Dobrowsky, R.T., and Chao, M.V. (1996). Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716-719.

Chao, M.V. and Hempstead, B.L. (1995). p75 and Trk: a two-receptor system. Trends in Neurosciences 18, 321-326.

Choi-Lundberg, D.L. and Bohn, M.C. (1995). Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Developmental Brain Research 85, 80-88.

Choi-Lundberg, D.L., Lin, Q., Chang, Y.N., Chiang, Y.L., Hay, C.M., Mohajeri, H., Davidson, B.L., and Bohn, M.C. (1997). Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275, 838-841.

Cohen, S. and Levi-Montalcini, R. (1956). A nerve growth-stimulating factor isolated from snake venom. Proceedings of the National Academy of Sciences of the United States of America 42, 571-574.

Cotton, R.G. (1997). Slowly but surely towards better scanning for mutations. Trends in Genetics 13, 43-46.

Cox, D.R., Burmeister, M., Price, E.R., Kim, S., and Myers, R.M. (1990). Radiation hybrid mapping: a somatic cell genetic method for constructing high-resolution maps of mammalian chromosomes. Science 250, 245-250.

Davies, J., Lyon, M., Gallagher, J., and Garrod, D. (1995). Sulphated proteoglycan is required for collecting duct growth and branching but not nephron formation during kidney development. Development 121, 1507-1517.

deLapeyriere, O. and Henderson, C.E. (1997). Motoneuron differentiation, survival and synaptogenesis. Current Opinion in Genetics & Development 7, 642-650.

Donis-Keller, H., Dou, S., Chi, D., Carlson, K.M., Toshima, K., Lairmore, T.C., Howe, JR, Moley, J.F., Goodfellow, P., and Wells, S.A., Jr. (1993). Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Human Molecular Genetics 2, 851-856.

Durbec, P.L., Larsson-Blomberg, L.B., Schuchardt, A., Costantini, F., and Pachnis, V. (1996). Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts. Development 122, 349-358.

Edery, P., Attie, T., Amiel, J., Pelet, A., Eng, C., Hofstra, R.M., Martelli, H., Bidaud, C., Munnich, A., and Lyonnet, S. (1996). Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nature Genetics 12, 442-444.

Edery, P., Eng, C., Munnich, A., and Lyonnet, S. (1997). RET in human development and oncogenesis. Bioessays 19, 389-395.

Edery, P., Lyonnet, S., Mulligan, L.M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul-Fekete, C., Ponder, B.A., and Munnich, A. (1994). Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367, 378-380.

Eigenbrot, C. and Gerber, N. (1997). X-ray structure of glial cell-derived neurotrophic factor at 1.9 A resolution and implications for receptor binding. Nature Structural Biology 4, 435-438.

Ernfors, P., Ibáñez, C.F., Ebendal, T., Olson, L., and Persson, H. (1990). Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proceedings of the National Academy of Sciences of the United States of America 87, 5454-5458.

Foroud, T. (1997). Introduction to genetic linkage analysis. Cancer Investigation 15, 548-552.

Francke, U., de Martinville, B., Coussens, L., and Ullrich, A. (1983). The human gene for the beta subunit of nerve growth factor is located on the proximal short arm of chromosome 1. Science 222, 1248-1251.

Gash, D.M., Zhang, Z., Ovadia, A., Cass, W.A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P.A., Collins, F., Hoffer, B.J., and Gerhardt, G.A. (1996). Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255.

Gasser, T., Mullermyhsok, B., Wszolek, Z.K., Oehlmann, R., Calne, D.B., Bonifati, V, Bereznai, B., Fabrizio, E., Vieregge, P., and Horstmann, R.D. (1998). A susceptibility locus for Parkinsons-disease maps to chromosome 2p13. Nature Genetics 18, 262-265.

Gershon, M.D. (1997). Genes and lineages in the formation of the enteric nervous system. Current Opinion in Neurobiology 7, 101-109.

GFR-alpha nomenclature committee (1997). Nomenclature of GPI-linked receptors for the GDNF ligand family. Neuron 19, 485

Gorodinsky, A., Zimonjic, D.B., Popescu, N.C., and Milbrandt, J. (1997). Assignment of the gdnf family receptor alpha-1 (gfra1) to human chromosome band 10q26 by in situ hybridization. Cytogenetics & Cell Genetics 78, 289-290.

Greene, L.A. and Kaplan, D.R. (1995). Early events in neurotrophin signalling via Trk and p75 receptors. Current Opinion in Neurobiology 5, 579-587.

Grieco, M., Santoro, M., Berlingieri, M.T., Melillo, R.M., Donghi, R, Bongarzone, I., Pierotti, M.A., Della Porta, G., Fusco, A., and Vecchio, G. (1990). PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60, 557-563.

Gulati, R., Phadke, S.R., and Agarwal, S.S. (1997). Associated malformations in the family of a patient with Meckel syndrome: heterozygous expression? Journal of Medical Genetics 34, 937-938.

Gundersen, R.W. and Barrett, J.N. (1979). Neuronal chemotaxis: chick dorsal-root axons turn toward high concentrations of nerve growth factor. Science 206, 1079-1080.

Gundersen, R.W. and Barrett, J.N. (1980). Characterization of the turning response of dorsal root neurites toward nerve growth factor. Journal of Cell Biology 87, 546-554.

Götz, R., Koster, R., Winkler, C., Raulf, F., Lottspeich, F., Schartl, M., and Thoenen, H. (1994). Neurotrophin-6 is a new member of the nerve growth factor family. Nature 372, 266-269.

Hallbook, F., Ibanez, C.F., and Persson, H. (1991). Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 6, 845-858.

Heikkila, R.E., Hess, A., and Duvoisin, R.C. (1984). Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224, 1451-1453.

Heikkinen, M., Rintala, R., and Luukkonen, P. (1997). Long-term anal sphincter performance after surgery for Hirschsprung's disease. Journal of Pediatric Surgery 32, 1443-1446.

Hellmich, H.L., Kos, L., Cho, E.S., Mahon, K.A., and Zimmer, A. (1996). Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mechanisms of Development 54, 95-105.

Henderson, C.E., Phillips, H.S., Pollock, R.A., Davies, A.M., Lemeulle, C., Armanini, M., Simmons, L., Moffet, B., Vandlen, R.A., Simpson, L.C., (1994). GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266, 1062-1064.

Hendry, I.A. (1975). The response of adrenergic neurones to axotomy and nerve growth factor. Brain Research 94, 87-97.

Heuckeroth, R.O., Kotzbauer, P., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Zimonjic, D.B., Popescu, N.C., Johnson, E.M., Jr., and Milbrandt, J. (1997). Neurturin, a novel neurotrophic factor, is localized to mouse chromosome 17 and human chromosome 19p13.3. Genomics 44, 137-140.

Hirschsprung, H. (1888). Stuhltragheit Neugeborener in Folge von Dilatation und Hypertrophie des Colons. Jahrb Kinderheilk 27, 1-7.

Hoffer, B.J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, LF, and Gerhardt, G.A. (1994). Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neuroscience Letters 182, 107-111.

Hofstra, R.M., Osinga, J., and Buys, C.H. (1997). Mutations in Hirschsprung disease: when does a mutation contribute to the phenotype. European Journal of Human Genetics 5, 180-185.

Hofstra, R.M., Osinga, J., Tan-Sindhunata, G., Wu, Y., Kamsteeg, E.J., Stulp, R.P., van Ravenswaaij-Arts, C., Majoor-Krakauer, D., Angrist, M., Chakravarti, A., Meijers, C., and Buys, C.H. (1996). A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nature Genetics 12, 445-447.

Hofstra, R.M., Valdenaire, O., Arch, e., Osinga, J., Meijers, C., and Buys, C.H. (1998). A loss of function mutation in the Endothelin-Converting Enzyme 1 in a patient with Hirschsprung disease and cardiac defects. The Third International Meeting: Hirschsprung Disease and Related Neurochristopahties, Evian, France Feb. 5-8, 1998 (Abstract)

Hohn, A., Leibrock, J., Bailey, K., and Barde, Y.A. (1990). Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344, 339-341.

Hosoda, K., Hammer, R.E., Richardson, J.A., Baynash, A.G., Cheung, J.C., Giaid, A., and Yanagisawa, M. (1994). Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79, 1267-1276.

Huebner, K., Isobe, M., Chao, M., Bothwell, M., Ross, A.H., Finan, J., Hoxie, J.A., Sehgal, A., Buck, C.R., Lanahan, A., et al. (1986). The nerve growth factor receptor gene is at human chromosome region 17q12-17q22, distal to the chromosome 17 breakpoint in acute leukemias. Proceedings of the National Academy of Sciences of the United States of America 83, 1403-1407.

Hunot, S., Bernard, V., Faucheux, B., Boissiere, F., Leguern, E., Brana, C., Gautris, P.P., Guerin, J., Bloch, B., Agid, Y., and Hirsch, E.C. (1996). Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease. Journal of Neural Transmission 103, 1043-1052.

Inagaki, H., Bishop, A.E., Escrig, C., Wharton, J., Allen-Mersh, T.G., and Polak, J.M. (1991). Localization of endothelinlike immunoreactivity and endothelin binding sites in human colon. Gastroenterology 101, 47-54.

Indo, Y., Tsuruta, M., Hayashida, Y., Karim, M.A., Ohta, K., Kawano, T., Mitsubuchi, H., Tonoki, H., Awaya, Y., and Matsuda, I. (1996). Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nature Genetics 13, 485-488.

Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., and Masaki, T. (1989). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proceedings of the National Academy of Sciences of the United States of America 86, 2863-2867.

Ishizaka, Y., Itoh, F., Tahira, T., Ikeda, I., Sugimura, T., Tucker, J., Fertitta, A, Carrano, A.V., and Nagao, M. (1989). Human ret proto-oncogene mapped to chromosome 10q11.2. Oncogene 4, 1519-1521.

Ito, S., Iwashita, T., Asai, N., Murakami, H., Iwata, Y., Sobue, G., Takahashi, and M. (1997). Biological properties of ret with cysteine mutations correlate with multiple endocrine neoplasia type 2a, familial medullary thyroid carcinoma, and hirschsprungs-disease phenotype. Cancer Research 57, 2870-2872.

Ivanchuk, S.M., Myers, S.M., Eng, C., and Mulligan, L.M. (1996). De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease. Human Molecular Genetics 5, 2023-2026.

Jing, S., Wen, D., Yu, Y., Holst, P.L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., Louis, J.C., Hu, S., Altrock, B.W., and Fox, G.M. (1996). GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85, 1113-1124.

Jing, S.Q., Yu, Y.B., Fang, M., Hu, Z., Holst, P.L., Boone, T., Delaney, J., Schultz, H, Zhou, R.P., and Fox, G.M. (1997). Gfr-alpha-2 and gfr-alpha-3 are two new receptors for ligands of the gdnf family. Journal of Biological Chemistry 272, 33111-33117.

Johnson D. Lanahan A. Buck CR. Sehgal A. Morgan C. Mercer E. Bothwell M. Chao M . (1986). Expression and structure of the human NGF receptor. Cell. 47:545-554.

Josso, N. and di Clemente, N. (1997). Serine/threonine kinase receptors and ligands. Current Opinion in Genetics & Development 7, 371-377.

Jungbluth, S., Bailey, K., and Barde, Y.A. (1994). Purification and characterisation of a brain-derived neurotrophic factor/neurotrophin-3 (BDNF/NT-3) heterodimer. European Journal of Biochemistry 221, 677-685.

Kallunki, P., Sainio, K., Eddy, R., Byers, M., Kallunki, T., Sariola, H., Beck, K, Hirvonen, H., Shows, T.B., and Tryggvason, K. (1992). A truncated laminin chain homologous to the B2 chain: structure, spatial expression, and chromosomal assignment. Journal of Cell Biology 119, 679-693.

Kaplan, D.R., Hempstead, B.L., Martin-Zanca, D., Chao, M.V., and Parada, L.F. (1991). The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252, 554-558.

Kaplan, D.R. and Miller, F.D. (1997). Signal transduction by the neurotrophin receptors. Current Opinion in Cell Biology 9, 213-221.

Kapur, R.P., Yost, C., and Palmiter, R.D. (1992). A transgenic model for studying development of the enteric nervous system in normal and aganglionic mice. Development 116, 167-175.

Kearns, C.M. and Gash, D.M. (1995). GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Research 672, 104-111.

Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., and Shimzu, N. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608.

Klein, R.D., Sherman, D., Ho, W.H., Stone, D., Bennett, G.L., Moffat, B., Vandlen, R, Simmons, L., Gu, Q., Hongo, J.A., Devaux, B., Poulsen, K., Armanini, M., Nozaki, C., Asai, N., Goddard, A., Phillips, H., Henderson, C.E., Takahashi, M., and Rosenthal, A. (1997). A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387, 717-721.

Korsching, S. (1993). The neurotrophic factor concept: a reexamination. Journal of Neuroscience 13, 2739-2748.

Kotzbauer, P.T., Lampe, P.A., Heuckeroth, R.O., Golden, J.P., Creedon, D.J., Johnson, EM J, and Milbrandt, J. (1996). Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384, 467-470.

Lane, P.W. (1966). Association of megacolon with two recessive spotting genes in the mouse. Journal of Heredity 57, 29-31.

Langer, J.C., Fitzgerald, P.G., Winthrop, A.L., Srinathan, S.K., Foglia, R.P., Skinner, M.A., Ternberg, J.L., and Lau, G.Y. (1996). One-stage versus two-stage Soave pull-through for Hirschsprung's disease in the first year of life. Journal of Pediatric Surgery 31, 33-6; discussion 36-7.

Lapchak, P.A., Gash, D.M., Jiao, S., Miller, P.J., and Hilt, D. (1997). Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease. Experimental Neurology 144, 29-34.

Le Douarin, N.M. and Teillet, M.A. (1973). The migration of neural crest cells to the wall of the digestive tract in avian embryo. Journal of Embryology & Experimental Morphology 30, 31-48.

Leibrock, J., Lottspeich, F., Hohn, A., Hofer, M., Hengerer, B., Masiakowski, P., Thoenen, H., and Barde, Y.A. (1989). Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341, 149-152.

Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science 237, 1154-1162.

Levi-Montalcini, R., Aloe, L., Mugnaini, E., Oesch, F., and Thoenen, H. (1975). Nerve growth factor induces volume increase and enhances tyrosine hydroxylase synthesis in chemically axotomized sympathetic ganglia of newborn rats. Proceedings of the National Academy of Sciences of the United States of America 72, 595-599.

Lewin, G.R. and Barde, Y.A. (1996). Physiology of the neurotrophins. Annual Review of Neuroscience 19, 289-317.

Li, L., Wu, W., Lin, L.F., Lei, M., Oppenheim, R.W., and Houenou, L.J. (1995). Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proceedings of the National Academy of Sciences of the United States of America 92, 9771-9775.

Lin, L.F. (1996). Glial Cell Line-Derived Neurotrophic Factor (GDNF): A Comprehensive Review. Neural Notes 2, 3-7.

Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S., and Collins, F. (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.

Liu, X., Vega, Q.C., Decker, R.A., Pandey, A., Worby, C.A., and Dixon, J.E. (1996). Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities. Journal of Biological Chemistry 271, 5309-5312.

Lo, L. and Anderson, D.J. (1995). Postmigratory neural crest cells expressing c-RET display restricted developmental and proliferative capacities. Neuron 15, 527-539.

Maisonpierre, P.C., Belluscio, L., Squinto, S., Ip, N.Y., Furth, M.E., Lindsay, R.M., and Yancopoulos, G.D. (1990). Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 247, 1446-1451.

Maisonpierre, P.C., Le Beau, M.M., Espinosa, R., 3d, Ip, N.Y., Belluscio, L., de l, Monte, S.M., Squinto, S., Furth, M.E., and Yancopoulos, G.D. (1991). Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 10, 558-568.

Martin-Zanca, D., Hughes, S.H., and Barbacid, M. (1986). A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319, 743-748.

Martucciello, G., Bertagnon, M., Favre, A., Brizzolara, A., Lerone, M., Briano, S., Mazzola, C., and Jasonni, V. (1998). What is the best diagnostic protocol for the study of Hirschsprung phenotype? The Third International Meeting: Hirschsprung Disease and Related Neurochristopahties, Evian, France Feb. 5-8, 1998 (Abstract)

Martucciello, G., Favre, A., Takahashi, M., and Jasonni, V. (1995). Immunohistochemical localization of RET protein in Hirschsprung's disease. Journal of Pediatric Surgery 30, 433-436.

Masure, S., Cik, M., Pangalos, M.N., Bonaventure, P., Verhasselt, P., Lesage, ASJ, Leysen, J.E., and Gordon, R.D. (1998). Molecular cloning, expression and tissue distribution of glial-cell-line-derived neurotrophic factor family receptor alpha-3 (gfr-alpha-3). European Journal of Biochemistry 251, 622-630.

Milbrandt, J., Desauvage, F.J., Fahrner, T.J., Baloh, R.H., Leitner, M.L., Tansey, MG, Lampe, P.A., Heuckeroth, R.O., Kotzbauer, P.T., Simburger, K.S., Golden, J.P., Davies, J.A., Vejsada, R., Kato, A.C., Hynes, M., Sherman, D., Nishimura, M., Wang, LC, Vandlen, R., Moffat, B., Klein, R.D., Poulsen, K., Gray, C., Garces, A., Henderson, C.E., et al. (1998). Persephin, a novel neurotrophic factor related to gdnf and neurturin. Neuron 20, 245-253.

Molenaar, J.C., Tibboel, D., van der Kamp, A.W., and Meijers, J.H. (1989). Diagnosis of innervation-related motility disorders of the gut and basic aspects of enteric nervous system development. Progress in Pediatric Surgery 24, 173-185.

Moore, M.W., Klein, R.D., Farinas, I., Sauer, H., Armanini, M., Phillips, H., Reichardt, L.F., Ryan, A.M., Carver-Moore, K., and Rosenthal, A. (1996). Renal and neuronal abnormalities in mice lacking GDNF. Nature 382, 76-79.

Mulligan, L.M., Kwok, J.B., Healey, C.S., Elsdon, M.J., Eng, C., Gardner, E., Love, D.R., Mole, S.E., Moore, J.K., Papi, L., et al. (1993). Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458-460.

Muragaki, Y., Chou, T.T., Kaplan, D.R., Trojanowski, J.Q., and Lee, V.M. (1997). Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors. Journal of Neuroscience 17, 530-542.

Myers, R.M., Maniatis, T., and Lerman, L.S. (1987). Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods in Enzymology 155, 501-527.

Myers, S.M., Eng, C., Ponder, B.A., and Mulligan, L.M. (1995). Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET. Oncogene 11, 2039-2045.

Myers, S.M., Salomon, R., Goessling, A., Pelet, A., von Deimling, A., Lyonnet, S., and Mulligan, L.M. (1998). Analysis of the GFRa family in Hirschsprung Disease. The Third International Meeting: Hirschsprung Disease and Related Neurochristopahties, Evian, France Feb. 5-8, 1998 (Abstract)

Nagamine, C.M., Chan, K., and Lau, Y.F. (1989). A PCR artifact: generation of heteroduplexes. American Journal of Human Genetics 45, 337-339.

Nakagawara, A., Arima-Nakagawara, M., Scavarda, N.J., Azar, C.G., Cantor, A.B., and Brodeur, G.M. (1993). Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. New England Journal of Medicine 328, 847-854.

Nakagawara, A., Liu, X.G., Ikegaki, N., White, P.S., Yamashiro, D.J., Nycum, L.M., Biegel, J.A., and Brodeur, G.M. (1995). Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2). Genomics 25, 538-546.

Naveilhan, P., Baudet, C., Mikaels, A., Shen, L.Y., Westphal, H., and Ernfors, P. (1998). Expression and regulation of gfr-alpha-3, a glial cell line-derived neurotrophic factor family receptor. Proceedings of the National Academy of Sciences of the United States of America 95, 1295-1300.

Nguyen, Q.T., Parsadanian, A.S., Snider, W.D., and Lichtman, J.W. (1998). Hyperinnervation of neuromuscular junctions caused by gdnf overexpression in muscle. Science 279, 1725-1729.

Nussbaum, R.L. (1998). Putting the Parkin into Parkinson's. Nature 392, 544-555.

O'Dell, K., Staren, E., and Bassuk, A. (1987). Total colonic aganglionosis (Zuelzer-Wilson syndrome) and congenital failure of automatic control of ventilation (Ondine's curse). Journal of Pediatric Surgery 22, 1019-1020.

Ohiwa, M., Murakami, H., Iwashita, T., Asai, N., Iwata, Y., Imai, T., Funahashi, H., Takagi, H., and Takahashi, M. (1997). Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations. Biochemical & Biophysical Research Communications 237, 747-751.

Oppenheim, R.W., Houenou, L.J., Johnson, J.E., Lin, L.F., Li, L., Lo, A.C., Newsome, A.L., Prevette, D.M., and Wang, S. (1995). Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373, 344-346.

Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. (1989). Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proceedings of the National Academy of Sciences of the United States of America 86, 2766-2770.

Paavola, P., Salonen, R., Baumer, A., Schinzel, A., Boyd, P.A., Gould, S., Meusburger, H., Tenconi, R., Barnicoat, A., Winter, R., and Peltonen, L. (1997). Clinical and genetic heterogeneity in Meckel syndrome. Human Genetics 101, 88-92.

Paavola, P., Salonen, R., Weissenbach, J., and Peltonen, L. (1995). The locus for Meckel syndrome with multiple congenital anomalies maps to chromosome 17q21-q24. Nature Genetics 11, 213-215.

Pachnis, V., Mankoo, B., and Costantini, F. (1993). Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119, 1005-1017.

Pandey, A., Duan, H., Di Fiore, P.P., and Dixit, V.M. (1995). The Ret receptor protein tyrosine kinase associates with the SH2-containing adapter protein Grb10. Journal of Biological Chemistry 270, 21461-21463.

Parboosingh, J.S., Rousseau, M., Rogan, F., Amit, Z., Chertkow, H., Johnson, W.G., Manganaro, F., Schipper, H.N., Curran, T.J., Stoessl, J., et al. (1995). Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease. Archives of Neurology 52, 1160-1163.

Pasini, B., Borrello, M.G., Greco, A., Bongarzone, I., Luo, Y., Mondellini, P., Alberti, L., Miranda, C., Arighi, E., Bocciardi, R., et al. (1995). Loss of function effect of RET mutations causing Hirschsprung disease. Nature Genetics 10, 35-40.

Pasini, B., Ceccherini, I., and Romeo, G. (1996). RET mutations in human disease. Trends in Genetics 12, 138-144.

Passarge, E. (1967). The genetics of Hirschsprung's disease. Evidence for heterogeneous etiology and a study of sixty-three families. New England Journal of Medecine 276, 138-143.

Pichel, J.G., Shen, L., Sheng, H.Z., Granholm, A.C., Drago, J., Grinberg, A., Lee, EJ, Huang, S.P., Saarma, M., Hoffer, B.J., Sariola, H., and Westphal, H. (1996). Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382, 73-76.

Pingault, V., Bondurand, N., Kuhlbrodt, K., Goerich, D.E., Prehu, M.O., Puliti, A., Herbarth, B., Hermans-Borgmeyer, I., Legius, E., Matthijs, G., Amiel, J., Lyonnet, S., Ceccherini, I., Romeo, G., Smith, J.C., Read, A.P., Wegner, M., and Goossens, M. (1998). SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nature Genetics 18, 171-173.

Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S, Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., Di Iorio, G., Golbe, L.I., and Nussbaum, R.L. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.

Puffenberger, E.G., Hosoda, K., Washington, S.S., Nakao, K., deWit, D., Yanagisawa, M., and Chakravart, A. (1994). A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79, 1257-1266.

Rapola, J. (1989). Kidneys in Meckel's syndrome as a model of abnormal renal differentiation. International Journal of Developmental Biology 33, 177-182.

Rapola, J. and Salonen, R. (1985). Visceral anomalies in the Meckel syndrome. Teratology 31, 193-201.

Ritvos, O., Tuuri, T., Eramaa, M., Sainio, K., Hilden, K., Saxen, L., Gilbert, and SF. (1995). Activin disrupts epithelial branching morphogenesis in developing glandular organs of the mouse. Mechanisms of Development 50, 229-245.

Rosenthal, A. (1997). Multicomponent Receptors for the GDNF/Neurturin Protein Family. Neural Notes 3, 3-7.

Rothman, T.P., Le Douarin, N.M., Fontaine-Perus, J.C., and Gershon, M.D. (1990). Developmental potential of neural crest-derived cells migrating from segments of developing quail bowel back-grafted into younger chick host embryos. Development 109, 411-423.

Roume, J., Ma, H.W., Le Merrer, M., Cormier-Daire, V., Girlich, D., Genin, E., and Munnich, A. (1997). Genetic heterogeneity of Meckel syndrome. Journal of Medical Genetics 34, 1003-1006.

Sakamoto, A., Yanagisawa, M., Sakurai, T., Takuwa, Y., Yanagisawa, H., Masaki, and T. (1991). Cloning and functional expression of human cDNA for the ETB endothelin receptor. Biochemical & Biophysical Research Communications 178, 656-663.

Salomon, R., Attie, T., Pelet, A., Bidaud, C., Eng, C., Amiel, J., Sarnacki, S., Goulet, O., Ricour, C., Nihoul-Fekete, C., Munnich, A., and Lyonnet, S. (1996). Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nature Genetics 14, 345-347.

Salomon, R., Bolk, S., Deray, B., Pelet, A., Amiel, J., Attie, T., Munnich, A., Chakravarti, A., and Lyonnet, S. (1998). Ret ligands mutations in Hirschsprung diseae in combination with Ret mutations: a model of multigenic heredity. The Third International Meeting: Hirschsprung Disease and Related Neurochristopahties, Evian, France Feb. 5-8, 1998 (Abstract)

Salonen, R. (1984). The Meckel syndrome: clinicopathological findings in 67 patients. American Journal of Medical Genetics 18, 671-689.

Salonen, R. and Norio, R. (1984). The Meckel syndrome in Finland: epidemiologic and genetic aspects. American Journal of Medical Genetics 18, 691-698.

Salonen, R. and Paavola, P. (1998). Meckel syndrome. Journal of Medical Genetics 35,

Sanchez, M.P., Silos-Santiago, I., Frisen, J., He, B., Lira, S.A., and Barbacid, M. (1996). Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382, 70-73.

Sanicola, M., Hession, C., Worley, D., Carmillo, P., Ehrenfels, C., Walus, L., Robinson, S., Jaworski, G., Wei, H., Tizard, R., Whitty, A., Pepinsky, R.B., Cate, and RL. (1997). Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proceedings of the National Academy of Sciences of the United States of America 94, 6238-6243.

Santoro, M., Carlomagno, F., Romano, A., Bottaro, D.P., Dathan, N.A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M.H., et al. (1995). Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267, 381-383.

Santoro, M., Wong, W.T., Aroca, P., Santos, E., Matoskova, B., Grieco, M., Fusco, A., and Di Fiore, P.P. (1994). An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway. Molecular & Cellular Biology 14, 663-675.

Sariola, H., Saarma, M., Sainio, K., Arumae, U., Palgi, J., Vaahtokari, A., Thesleff, I., and Karavanov, A. (1991). Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science 254, 571-573.

Sariola, H., Sainio, K., Arumae, U., and Saarma, M. (1994). Neurotrophins and ciliary neurotrophic factor: their biology and pathology. Annals of Medicine 26, 355-363.

Sauer, H., Rosenblad, C., and Bjorklund, A. (1995). Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proceedings of the National Academy of Sciences of the United States of America 92, 8935-8939.

Saxén, L. (1987). Organogenesis of the Kidney (Cambridge: Cambridge University Press).

Schindelhauer, D., Schuffenhauer, S., Gasser, T., Steinkasserer, A., Meitinger, and T. (1995). The gene coding for glial cell line derived neurotrophic factor (GDNF) maps to chromosome 5p12-p13.1. Genomics 28, 605-607.

Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F., and Pachnis, V. (1994). Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367, 380-383.

Segal, R.A., Goumnerova, L.C., Kwon, Y.K., Stiles, C.D., and Pomeroy, S.L. (1994). Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proceedings of the National Academy of Sciences of the United States of America 91, 12867-12871.

Segal, R.A. and Greenberg, M.E. (1996). Intracellular signaling pathways activated by neurotrophic factors. Annual Review of Neuroscience 19, 463-489.

Sepulveda, W., Sebire, N.J., Souka, A., Snijders, R.J., and Nicolaides, K.H. (1997). Diagnosis of the Meckel-Gruber syndrome at eleven to fourteen weeks' gestation. American Journal of Obstetrics & Gynecology 176, 316-319.

Serbedzija, G.N., Burgan, S., Fraser, S.E., and Bronner-Fraser, M. (1991). Vital dye labelling demonstrates a sacral neural crest contribution to the enteric nervous system of chick and mouse embryos. Development 111, 857-866.

Simon, H., LeMoal, M., Galey, D., and Cardo, B. (1974). Selective degeneration of central dopaminergic systems after injection of 6-hydroxydopamine in the ventral mesencephalic tegmentum of the rat. Demonstration by the Fink-Heimer strain. Experimental Brain Research 20, 375-384.

Snider, W.D. (1994). Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77, 627-638.

Southard-Smith, E.M., Kos, L., and Pavan, W.J. (1998). Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nature Genetics 18, 60-64.

Southern, E.M. (1996). DNA chips: analysing sequence by hybridization to oligonucleotides on a large scale. Trends in Genetics 12, 110-115.

Suomalainen, A., Ciafaloni, E., Koga, Y., Peltonen, L., DiMauro, S., and Schon, E.A. (1992). Use of single strand conformation polymorphism analysis to detect point mutations in human mitochondrial DNA. Journal of the Neurological Sciences 111, 222-226.

Suter-Crazzolara, C. and Unsicker, K. (1994). GDNF is expressed in two forms in many tissues outside the CNS. Neuroreport 5, 2486-2488.

Suvanto, P., Hiltunen, J.O., Arumae, U., Moshnyakov, M., Sariola, H., Sainio, K., and Saarma, M. (1996). Localization of glial cell line-derived neurotrophic factor (GDNF) mRNA in embryonic rat by in situ hybridization. European Journal of Neuroscience 8, 816-822.

Suvanto, P., Wartiovaara, K., Lindahl, M., Arumae, U., Moshnyakov, M., Horelli-Kuitunen, N., Airaksinen, M.S., Palotie, A., Sariola, H., and Saarma, M. (1997). Cloning, mRNA distribution and chromosomal localisation of the gene for glial cell line-derived neurotrophic factor receptor beta, a homologue to GDNFR-alpha. Human Molecular Genetics 6, 1267-1273.

Suvanto, P. (1997). Developmental roles of GDNF and characterization of its receptors (Academic diseertation)

Syvänen, A.C., Sajantila, A., and Lukka, M. (1993). Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. American Journal of Human Genetics 52, 46-59.

Takahashi, M., Ritz, J., and Cooper, G.M. (1985). Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42, 581-588.

Tam, P.K., Gould, S.J., Martucciello, G., Biddolph, S., Takahashi, M., and Jasonni, V. (1996). Ret protein in the human fetal rectum. Journal of Pediatric Surgery 31, 568-571.

Temlett, J.A. (1996). Parkinson's disease: biology and aetiology. Current Opinion in Neurology 9, 303-307.

the kidney database (1998). http://www. ana. ed. ac. uk/anatomy/database/kidbase/mutantk. html

Tomac, A., Lindqvist, E., Lin, L.F., Ogren, S.O., Young, D., Hoffer, B.J., and Olson, L. (1995). Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.

Treanor, J.J., Goodman, L., de Sauvage, F., Stone, D.M., Poulsen, K.T., Beck, C.D., Gray, C., Armanini, M.P., Pollock, R.A., Hefti, F., Phillips, H.S., Goddard, A., Moore, M.W., Buj-Bello, A., Davies, A.M., Asai, N., Takahashi, M., Vandlen, R., Henderson, C.E., and Rosenthal, A. (1996). Characterization of a multicomponent receptor for GDNF. Nature 382, 80-83.

Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.S., Sieber, B.A., Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Arumae, U., et al. (1996). Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381, 785-788.

Trupp, M., Belluardo, N., Funakoshi, H., and Ibanez, C.F. (1997). Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. Journal of Neuroscience 17, 3554-3567.

Trupp, M., Ryden, M., Jornvall, H., Funakoshi, H., Timmusk, T., Arenas, E., and Ibanez, C.F. (1995). Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. Journal of Cell Biology 130, 137-148.

Umbhauer, M., Marshall, C.J., Mason, C.S., Old, R.W., and Smith, J.C. (1995). Mesoderm induction in Xenopus caused by activation of MAP kinase. Nature 376, 58-62.

Valent, A., Danglot, G., and Bernheim, A. (1997). Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization. European Journal of Human Genetics 5, 102-104.

van Leeuwen, F.W., de Kleijn, D.P., van den Hurk, H.H., Neubauer, A., Sonnemans, MA, Sluijs, J.A., Koycu, S., Ramdjielal, R.D.J., Salehi, A., Martens, G.J.M., Grosveld, F.G., Peter, J., Burbach, H., and Hol, E.M. (1998). Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279, 242-247.

Vega, Q.C., Worby, C.A., Lechner, M.S., Dixon, J.E., and Dressler, G.R. (1996). Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. Proceedings of the National Academy of Sciences of the United States of America 93, 10657-10661.

Watanabe, Y., Harada, T., Ito, T., Ishiguro, Y., Ando, H., Seo, T., Kobayashi, S., Takahashi, M., and Nimura, Y. (1997). ret Proto-oncogene product is a useful marker of lineage determination in the development of the enteric nervous system in rats. Journal of Pediatric Surgery 32, 28-33.

Weier, H.U., Rhein, A.P., Shadravan, F., Collins, C., and Polikoff, D. (1995). Rapid physical mapping of the human trk protooncogene (NTRK1) to human chromosome 1q21-q22 by P1 clone selection, fluorescence in situ hybridization (FISH), and computer-assisted microscopy. Genomics 26, 390-393.

Widenfalk, J., Nosrat, C., Tomac, A., Westphal, H., Hoffer, B., and Olson, L. (1997). Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNFR-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. Journal of Neuroscience 17, 8506-8519.

Wilkinson, D. and Green, P. (1998). In situ hybridisation and the three-dimensional reconstruction of serial sections. In Postimplantation mammalian embryos. A practical approach. A. Copp and D. Cockroft, eds. (London: Oxford University Press), pp. 155-171.

Worby, C.A., Vega, Q.C., Chao, H.H.J., Seasholtz, A.F., Thompson, R.C., and Dixon, J.E. (1998). Identification and characterization of gfr-alpha-3, a novel co-receptor belonging to the glial cell line-derived neurotrophic receptor family. Journal of Biological Chemistry 273, 3502-3508.

Yan, Q., Matheson, C., and Lopez, O.T. (1995). In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373, 341-344.

Yanagisawa, M., Inoue, A., Ishikawa, T., Kasuya, Y., Kimura, S., Kumagaye, S., Nakajima, K., Watanabe, T.X., Sakakibara, S., Goto, K., et al. (1988). Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proceedings of the National Academy of Sciences of the United States of America 85, 6964-6967.

Zhou, S., Carraway, K.L., 3rd, Eck, M.J., Harrison, S.C., Feldman, R.A., Mohammadi, M., Schlessinger, J., Hubbard, S.R., Smith, D.P., Eng, C., et al. (1995). Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373, 536-539.